Edition:
United States

StemCells Inc (STEM.OQ)

STEM.OQ on NASDAQ Stock Exchange Capital Market

--USD
--
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
40,425
52-wk High
$59.40
52-wk Low
$2.97

STEM.OQ

Chart for STEM.OQ

About

StemCells, Inc. (StemCells) is engaged in the research, development and commercialization of stem cell therapeutics. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies. Its lead product development program is its central nervous system (CNS) program, in... (more)

Overall

Beta: 0.25
Market Cap(Mil.): $20.81
Shares Outstanding(Mil.): 16.26
Dividend: --
Yield (%): --

Financials

  STEM.OQ Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -2.04 -- --
ROI: -232.54 -1.09 14.95
ROE: -812.22 -2.39 16.29

BRIEF-StemCells and units entered into asset purchase agreement with Boco Silicon Valley on Nov. 11

* On November 11, 2016 co & units entered into an asset purchase agreement with Boco Silicon Valley -sec filing

Nov 15 2016

BRIEF-Stemcells says respective boards of co and Microbot approved merger agreement

* Respective boards of directors of stemcells and microbot have approved merger agreement - sec filing

Aug 15 2016

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF68.75 -0.10
Pfizer Inc. (PFE.N) $31.63 +0.17
Roche Holding Ltd. (ROG.S) CHF220.60 -1.60
Roche Holding Ltd. (RO.S) CHF224.60 -1.10
Merck & Co., Inc. (MRK.N) $61.13 +0.37
Sanofi SA (SASY.PA) €75.30 +0.14
Abbott Laboratories (ABT.N) $37.90 +0.30
Amgen, Inc. (AMGN.OQ) $144.01 +1.62
Merck KGaA (MRCG.DE) €92.54 +0.17
Biogen Inc (BIIB.OQ) $297.19 +1.41

Earnings vs. Estimates